Balyasny Asset Management’s CME Group CME Stock Holding History

Balyasny Asset Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,700	Closed	-$1.28M	–	2963
2025 Q4	$1.28M	Buy	4,700 +2,000	+74%	+$543K	﹤0.01%	2073
2025 Q3	$730K	Sell	2,700 -1,500	-36%	-$408K	﹤0.01%	2243
2025 Q2	$1.16M	Sell	4,200 -3,600	-46%	-$979K	﹤0.01%	1994
2025 Q1	$2.07M	Sell	7,800 -200	-3%	-$49.3K	﹤0.01%	1686
2024 Q4	$1.86M	Sell	8,000 -157,000	-95%	-$36.1M	﹤0.01%	1694
2024 Q3	$36.4M	Buy	+165,000	New	+$34.1M	0.06%	415
2023 Q1	–	Sell	-29,400	Closed	-$4.94M	–	2711
2022 Q4	$4.94M	Hold	29,400	–	–	0.01%	1039
2022 Q3	$5.21M	Buy	29,400 +21,900	+292%	+$4.33M	0.02%	969
2022 Q2	$1.53M	Buy	+7,500	New	+$1.59M	0.01%	1547

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Balyasny Asset Management's CME Position: Q1 2026 in Review

Balyasny Asset Management increased its CME Group (CME) stake by 702% in Q1 2026, buying an estimated $121M and bringing the position to 464,624 shares worth $137M. The position accounts for 0.18% of the portfolio, ranked #113.

Balyasny Asset Management first reported a position in CME in Q2 2013 and has held it in 51 quarters since. The position peaked at $284M in Q3 2024. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Balyasny Asset Management held 464,624 shares of CME Group worth $137M as of Q1 2026.
Balyasny Asset Management bought 406,721 CME Group shares in Q1 2026, an estimated $121M.
CME Group made up 0.18% of Balyasny Asset Management's portfolio in Q1 2026, its #113 holding.
Balyasny Asset Management first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
Balyasny Asset Management's CME Group position peaked at $284M in Q3 2024.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.